Keryx Biopharmaceuticals (KERX)

Keryx Biopharmaceuticals, Inc. (KERX) CEO Jodie Morrison on Q2 2018 Results - Earnings Call Transcr
Aug. 8, 2018 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Jodie Morrison on Q1 2018 Results - Earnings Call Transcript
May 10, 2018 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Gregory Madison on Q4 2017 Results - Earnings Call Transcript
Feb. 7, 2018 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Gregory Madison on Q3 2017 Results - Earnings Call Transcript
Nov. 7, 2017 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Greg Madison on Q2 2017 Results - Earnings Call Transcript
July 27, 2017 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Greg Madison on Q1 2017 Results - Earnings Call Transcript
May 4, 2017 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Gregory Madison on Q4 2016 Results - Earnings Call Transcript
March 1, 2017 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Gregory Madison on Q3 2016 Results - Earnings Call Transcript
Nov. 9, 2016 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Greg Madison on Q2 2016 Results - Earnings Call Transcript
Aug. 1, 2016 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Greg Madison on Q1 2016 Results - Earnings Call Transcript
April 28, 2016 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals (KERX) Q4 2015 Results - Earnings Call Webcast
Feb. 25, 2016 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Greg Madison on Q4 2015 Results - Earnings Call Transcript
Feb. 25, 2016 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals (KERX) Q3 2015 Results - Earnings Call Webcast
Oct. 29, 2015 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Greg Madison on Q3 2015 Results - Earnings Call Transcript
Oct. 29, 2015 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals (KERX) Q2 2015 Results - Earnings Call Webcast
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Greg Madison on Q2 2015 Results - Earnings Call Transcript
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals (KERX) Q1 2015 Results - Earnings Call Webcast
May 4, 2015 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Greg Madison on Q1 2015 Results - Earnings Call Transcript
May 4, 2015 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals (KERX) Q4 2014 Results - Earnings Call Webcast
Feb. 27, 2015 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur on Q4 2014 Results - Earnings Call Transcript
Feb. 27, 2015 | Price: Free! | Source: Seeking Alpha

Keryx's (KERX) CEO Ron Bentsur on Q3 2014 Results - Earnings Call Transcript
Nov. 6, 2014 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals (KERX) Q3 2014 Results - Earnings Call Webcast
Nov. 6, 2014 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur Discusses FDA approval of Ferric Citrate (Transcri
Sept. 8, 2014 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur on Q2 2014 Results - Earnings Call Transcript
Aug. 8, 2014 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals (KERX) Q2 2014 Results - Earnings Call Webcast
Aug. 8, 2014 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals ' Management Presents at 35th Annual Goldman Sachs Global Healthcare Confe
June 12, 2014 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur on Q1 2014 Results - Earnings Call Transcript
May 8, 2014 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript
March 13, 2014 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. - Q4 2013 Earnings Call Transcript
March 13, 2014 | Price: Free! | Source: Earnings Impact

Keryx Biopharmaceuticals, Inc. - 32nd Annual J.P. Morgan Healthcare Conference Transcript
Jan. 15, 2014 | Price: Free! | Source: Earnings Impact

Keryx Biopharmaceuticals CEO Presents at JPMorgan Healthcare Conference (Transcript)
Jan. 15, 2014 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 6, 2013 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. Q3 2013 Earnings Conference Call Transcript
Nov. 5, 2013 | Price: $106.00 | Source: Thomson

Keryx Biopharmaceuticals, Inc. at BioCentury NewsMakers in the Biotech Industry Conference Transcri
Sept. 27, 2013 | Price: $54.00 | Source: Thomson

Keryx Biopharmaceuticals' CEO Discusses at Stifel Nicolaus Weisel Healthcare Conference (Transcript
Sept. 12, 2013 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. at Rodman & Renshaw Global Investment Conference Transcript
Sept. 9, 2013 | Price: $54.00 | Source: Thomson

Keryx Biopharmaceuticals, Inc. - 15th Annual Rodman & Renshaw Global Investment Conference Transcr
Sept. 9, 2013 | Price: Free! | Source: Earnings Impact

Keryx Biopharmaceuticals, Inc. - Q2 2013 Earnings Call Transcript
Aug. 1, 2013 | Price: Free! | Source: Earnings Impact

Keryx Biopharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 1, 2013 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. Q2 2013 Earnings Conference Call Transcript
Aug. 1, 2013 | Price: $106.00 | Source: Thomson

Keryx Biopharmaceutical's CEO Discusses Q1 2013 Results - Earnings Call Transcript
May 8, 2013 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. Q1 2013 Earnings Conference Call Transcript
May 8, 2013 | Price: $106.00 | Source: Thomson

Keryx Biopharmaceuticals, Inc. at Roth Conference Transcript
March 18, 2013 | Price: $54.00 | Source: Thomson

Keryx Biopharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript
March 12, 2013 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. Q4 2012 Earnings Conference Call Transcript
March 12, 2013 | Price: $106.00 | Source: Thomson

Keryx Biopharmaceuticals' CEO Presents at Citi 2013 Global Healthcare Conference (Transcript)
Feb. 27, 2013 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. to Discuss Top-Line Results from Zerenexâ„¢ Phase 3 L
Jan. 28, 2013 | Price: $106.00 | Source: Thomson

Keryx Biopharmaceuticals' CEO Presents at Top-Line Results from Zerenex(TM) Phase 3 Long-Term Study
Jan. 28, 2013 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. at JPMorgan Global Healthcare Conference Transcript
Jan. 10, 2013 | Price: $54.00 | Source: Thomson

Keryx Biopharmaceuticals' CEO Presents at 31st Annual J.P. Morgan Healthcare Conference (Transcript
Jan. 10, 2013 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. at Oppenheimer Holdings Inc Healthcare Conference Transcript
Dec. 13, 2012 | Price: $54.00 | Source: Thomson

Keryx Biopharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Nov. 8, 2012 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. Q3 2012 Earnings Conference Call Transcript
Nov. 8, 2012 | Price: $106.00 | Source: Thomson

Keryx Biopharmaceuticals, Inc. at UBS Global Life Sciences Conference Transcript
Sept. 20, 2012 | Price: $54.00 | Source: Thomson

Keryx Biopharmaceuticals' CEO Presents at UBS Global Life Sciences Conference (Transcript)
Sept. 20, 2012 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug. 8, 2012 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. Q2 2012 Earnings Conference Call Transcript
Aug. 8, 2012 | Price: $54.00 | Source: Thomson

Keryx Biopharmaceuticals, Inc. at JMP Securities Healthcare Conference Transcript
July 13, 2012 | Price: $54.00 | Source: Thomson

Keryx Biopharmaceuticals, Inc. at Jefferies Global Healthcare Conference Transcript
June 4, 2012 | Price: $54.00 | Source: Thomson

Keryx Biopharmaceuticals, Inc. Q2 2008 Earnings Call Transcript
Aug. 11, 2008 | Price: Free! | Source: Seeking Alpha

Keryx Biopharmaceuticals, Inc. Q1 2008 Earnings Call Transcript
May 31, 2008 | Price: Free! | Source: Seeking Alpha

Recent filings

Securities registration termination [Section 12(g)] - Dec. 26, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Keryx Biopharmaceuticals Just Received a Notice of Effectiveness - Dec. 21, 2018

Major owner of Keryx Biopharmaceuticals just disposed of 25,791,678 shares - Dec. 13, 2018

Securities to be offered to employees in employee benefit plans, post-effective amendments - Dec. 13, 2018

Keryx Biopharmaceuticals's Interim CEO just disposed of 120,000 shares - Dec. 13, 2018

Post-effective amendment to registration statement [Rule 462(b)] - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018

Post-effective amendment to registration statement [Rule 462(b)] - Dec. 13, 2018

Securities to be offered to employees in employee benefit plans, post-effective amendments - Dec. 13, 2018

Securities to be offered to employees in employee benefit plans, post-effective amendments - Dec. 13, 2018

Securities to be offered to employees in employee benefit plans, post-effective amendments - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018

Keryx Biopharmaceuticals's Chief Operating Officer just disposed of 111,115 shares - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018


- Dec. 13, 2018

Post-effective amendment to registration statement [Rule 462(b)] - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018

Keryx Biopharmaceuticals's Chief Medical Officer just disposed of 148,279 shares - Dec. 13, 2018

Keryx Biopharmaceuticals director just disposed of 60,000 shares - Dec. 13, 2018

Securities to be offered to employees in employee benefit plans, post-effective amendments - Dec. 13, 2018

Securities to be offered to employees in employee benefit plans, post-effective amendments - Dec. 13, 2018

Keryx Biopharmaceuticals's Chief Financial Officer just disposed of 162,956 shares - Dec. 13, 2018

Seth A. Klarman just issued a filing suggesting it has sold all of its Keryx Biopharmaceuticals - Dec. 13, 2018

Keryx Biopharmaceuticals director just disposed of 30,000 shares - Dec. 13, 2018

Keryx Biopharmaceuticals director just disposed of 27,333 shares - Dec. 13, 2018

Securities to be offered to employees in employee benefit plans, post-effective amendments - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018

Keryx Biopharmaceuticals director just disposed of 10,000 shares - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018

Keryx Biopharmaceuticals director just disposed of 20,000 shares - Dec. 13, 2018

Keryx Biopharmaceuticals director just disposed of 186,666 shares - Dec. 13, 2018

Post-Effective amendments for registration statement - Dec. 13, 2018

Completion of Acquisition or Disposition of - Dec. 13, 2018

Securities to be offered to employees in employee benefit plans, post-effective amendments - Dec. 13, 2018

Securities to be offered to employees in employee benefit plans, post-effective amendments - Dec. 13, 2018

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities - Dec. 12, 2018

Prospectuses and communications, business combinations - Nov. 30, 2018

Prospectuses and communications, business combinations - Nov. 30, 2018

Prospectuses and communications, business combinations - Nov. 29, 2018

Prospectuses and communications, business combinations - Nov. 28, 2018

Keryx Biopharmaceuticals's Chief Medical Officer just disposed of 1,156 shares - Nov. 16, 2018

Keryx Biopharmaceuticals's Chief Financial Officer just disposed of 1,155 shares - Nov. 16, 2018

Prospectuses and communications, business combinations - Nov. 16, 2018

Prospectuses and communications, business combinations - Nov. 16, 2018

Prospectuses and communications, business combinations - Nov. 15, 2018

Prospectuses and communications, business combinations - Nov. 15, 2018

Keryx Biopharmaceuticals Announces Third Quarter 2018 Financial Results - Nov. 8, 2018

Keryx Biopharmaceuticals Just Filed Its Quarterly Report: Basic and Diluted Ne... - Nov. 8, 2018

Prospectuses and communications, business combinations - Nov. 8, 2018

Prospectuses and communications, business combinations - Oct. 30, 2018

Keryx Biopharmaceuticals's Chief Medical Officer just disposed of 1,253 shares - Oct. 30, 2018

Definitive proxy statement relating to merger or acquisition - Oct. 30, 2018

Prospectuses and communications, business combinations - Oct. 29, 2018

Keryx Biopharmaceuticals's Chief Operating Officer just disposed of 2,040 shares - Oct. 22, 2018

Prospectuses and communications, business combinations - Oct. 2, 2018

Prospectuses and communications, business combinations - Oct. 1, 2018

Entry into a Material Definitive - Oct. 1, 2018

Prospectuses and communications, business combinations - Oct. 1, 2018

Prospectuses and communications, business combinations - Sept. 14, 2018

Prospectuses and communications, business combinations - Sept. 14, 2018

Prospectuses and communications, business combinations - Sept. 6, 2018

Prospectuses and communications, business combinations - Sept. 6, 2018

Keryx Biopharmaceuticals's Chief Financial Officer just disposed of 1,185 shares - Aug. 16, 2018

Keryx Biopharmaceuticals's Chief Medical Officer just disposed of 1,186 shares - Aug. 16, 2018

Keryx Biopharmaceuticals Just Filed Its Quarterly Report: Basic and Diluted Ne... - Aug. 9, 2018

Prospectuses and communications, business combinations - Aug. 9, 2018

Entry into a Material Definitive - July 20, 2018

Keryx Biopharmaceuticals's Chief Operating Officer just disposed of 2,021 shares - July 19, 2018

Keryx Biopharmaceuticals director just picked up 10,000 shares - July 12, 2018

Keryx Biopharmaceuticals director just picked up 10,000 shares - July 12, 2018

Keryx Biopharmaceuticals director just picked up 10,000 shares - July 12, 2018

Keryx Biopharmaceuticals director just picked up 10,000 shares - July 12, 2018

Keryx Biopharmaceuticals director just picked up 10,000 shares - July 12, 2018

Keryx Biopharmaceuticals director just picked up 10,000 shares - July 12, 2018

Keryx Biopharmaceuticals's Interim CEO just picked up 10,000 shares - July 12, 2018

Prospectuses and communications, business combinations - July 11, 2018

Prospectuses and communications, business combinations - July 11, 2018

Seth A. Klarman just provided an update on activist position in Keryx Biopharmaceuticals - June 29, 2018

Prospectuses and communications, business combinations - June 28, 2018

Keryx: This Voting Agreement (This “ Agreement - June 28, 2018

Prospectuses and communications, business combinations - June 28, 2018

Keryx Biopharmaceuticals director just disposed of 1,667 shares - June 19, 2018

Keryx Biopharmaceuticals director just picked up 10,000 shares - June 18, 2018

Departure of Directors or Certain - June 15, 2018

Keryx Biopharmaceuticals director just disposed of 1,334 shares - June 12, 2018

Keryx Biopharmaceuticals director just disposed of 1,333 shares - May 31, 2018

Keryx Biopharmaceuticals director just disposed of 1,667 shares - May 31, 2018

Keryx Biopharmaceuticals Announces Data From An Investigator Sponsored Trial Of Ferric Citrate In Patients - May 25, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. VANGUARD GROUP INC 8,240,391 N/A Sept. 30, 2018
2. BlackRock Institutional Trust Company, N.A. 2,620,238 N/A Dec. 31, 2016
3. NORGES BANK 2,051,899 N/A March 31, 2018
4. BlackRock Fund Advisors 2,021,682 N/A Sept. 30, 2016
5. NORTHERN TRUST CORP 1,197,419 N/A June 30, 2018
6. MORGAN STANLEY 1,164,421 N/A June 30, 2018
7. MORGAN STANLEY 1,164,421 N/A June 30, 2018
8. NORTHERN TRUST CORP 1,093,563 N/A March 31, 2018
9. MANAGED ACCOUNT ADVISORS LLC 644,079 N/A June 30, 2015
10. MORGAN STANLEY 457,100 N/A Dec. 31, 2016
11. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
12. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
13. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
14. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
15. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
16. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
17. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
18. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
19. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
20. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
21. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
22. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
23. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
24. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
25. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
26. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
27. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
28. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
29. MORGAN STANLEY 418,255 N/A Sept. 30, 2018
30. Russell Frank Co/ 316,518 N/A Sept. 30, 2015

Keryx Biopharmaceuticals (KERX)

140
 


Feedback